Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
For these drugs to be worth the high costs, they need to show clear benefits and savings for the wider health care system
IGF2 increases de novo steroidogenesis in prostate cancer cells
Insurers may also calculate that the long-term health care cost savings due to a decline in obesity and related health issues is an attractive reason to pay for the treatments
As a GLP-1 receptor agonist, it mimics a naturally occurring gut hormone that slows down how quickly food leaves your stomach, signals areas of the brain that regulate appetite, and helps your pancreas release insulin more effectively
US$ 23.22
US$ 23.49
US$ 23.56
US$ 23.34
US$ 25.14
US$ 28.48
US$ 26.60
US$ 20.03
US$ 29.75
